Skip to main content
Diagnos Inc logo

Diagnos Inc — Investor Relations & Filings

Ticker · ADK ISIN · CA2524423068 LEI · 254900ZF529VWZDVUS82 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 288 across all filing types
Latest filing 2025-06-11 Regulatory Filings
Country CA Canada
Listing TSXV ADK

About Diagnos Inc

https://www.diagnos.com/

Diagnos Inc. is a technology company specializing in software-based services for the healthcare sector, focusing on the early detection of critical health problems. The company leverages its proprietary FLAIRE Artificial Intelligence (AI) platform, which combines contextual imaging and data analysis to develop algorithms, process images, and analyze data. A primary application of this technology is AI retina analysis for screening and monitoring diseases, such as diabetes, to prevent vision loss. Diagnos aims to enable digital transformation in healthcare by providing cost-effective early detection solutions to primary care facilities and specialists across international markets, including North America and Latin America.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed Form 13-502F1 submitted to the Ontario Securities Commission regarding participation fee calculations and certification by the issuer’s CFO. It is a regulatory filing rather than an annual report, earnings release, or management discussion. It does not fit any specific category like dividends, director dealings, or M&A. Therefore it falls under the fallback category for miscellaneous regulatory filings (RNS).
2025-06-11 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed Form 13-501F1 filed with the Alberta Securities Commission, containing management certification and fee calculations under Canadian securities rules. It is not an annual or interim financial report, earnings release, dividend notice, share transaction, or M&A announcement. It is a regulatory filing specific to participation fees and thus falls under the general “Regulatory Filings” category (RNS) as a fallback for miscellaneous mandated filings with a securities regulator.
2025-06-11 English
News release - French.pdf
Board/Management Information Classification · 1% confidence The document is a press release titled “COMMUNIQUÉ DE PRESSE” announcing that Ed Weiner has joined Diagnos Inc.’s U.S. advisory board. It is an announcement of a change in the company’s governance/advisory structure (a board-level appointment), which fits the definition of a Board/Management Information filing. There is no indication of an AGM, financial results, or detailed report publication. Therefore, it should be classified under MANG.
2025-06-10 French
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of Ed Weiner to the company’s Advisory Board, which constitutes a change in senior management/board information. It does not present financial results, filings, or solicit votes—it simply announces a board/advisory appointment. Thus it falls under Board/Management Information (MANG).
2025-06-10 English
52-109FV1 - Certification of annual filings - CEO (F).pdf
Regulatory Filings Classification · 1% confidence The document is a regulatory attestation (certificate) by the issuer's CEO under Canadian Regulation 52-109 for the annual documents of Diagnos inc. It is not the full Annual Report itself, nor an earnings release, proxy statement, or audit report in the narrow sense, but a standalone certification filed alongside annual financial reports. This does not neatly fit any specialized category above, so it falls into the fallback “Regulatory Filings” category (RNS).
2025-05-28 French
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 “Venture Issuer Basic Certificate” signed by the CEO certifying the annual filings (AIF, financial statements, MD&A) for the year ended March 31, 2025. It is not the actual annual report or financial statements themselves, nor is it an earnings release, MD&A narrative, audit report, or management discussion. It represents a regulatory compliance certificate under Canadian securities rules rather than substantive financial content. Therefore, it falls into the fallback category for miscellaneous regulatory filings.
2025-05-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.